Cipla | CIPLA - Interest Expense On Debt


Cipla reported INR170.3M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Arca Biopharma USD 4.6M 4.1M Mar/2026
aTyr Pharma 69.82M 9.83M Jun/2026
Bio Path 677K 547K Mar/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cara Therapeutics -89.64M 128.67M Dec/2025
Cipla INR 170.3M 39M Jun/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Immunic 197K 222K Dec/2025
Minerva Neurosciences USD 2.31M 60K Jun/2024
Nektar Therapeutics USD 7.94M 1.83M Mar/2026
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
TherapeuticsMD USD 20K 25K Sep/2023
UPL INR 8.36B 620M Mar/2026